Preface.

T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity (2007) 1.92

Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid. J Biol Chem (2002) 1.80

Structure of the s5a:k48-linked diubiquitin complex and its interactions with rpn13. Mol Cell (2009) 1.57

Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing. J Cell Biol (2007) 1.56

Mechanism of PKR activation: dimerization and kinase activation in the absence of double-stranded RNA. J Mol Biol (2005) 1.44

Mechanism of PKR Activation by dsRNA. J Mol Biol (2008) 1.42

NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity (2006) 1.27

Domain architecture and biochemical characterization of vertebrate Mcm10. J Biol Chem (2007) 1.19

Structure of CD84 provides insight into SLAM family function. Proc Natl Acad Sci U S A (2007) 1.17

RNA dimerization promotes PKR dimerization and activation. J Mol Biol (2009) 1.16

Global analysis of non-specific protein-nucleic interactions by sedimentation equilibrium. Biophys Chem (2004) 1.14

Analysis of PKR structure by small-angle scattering. J Mol Biol (2009) 1.14

Defining how ubiquitin receptors hHR23a and S5a bind polyubiquitin. J Mol Biol (2007) 1.09

Mechanism of interaction of the double-stranded RNA (dsRNA) binding domain of protein kinase R with short dsRNA sequences. Biochemistry (2007) 1.08

Unactivated PKR exists in an open conformation capable of binding nucleotides. Biochemistry (2006) 1.06

Interaction of the trp RNA-binding attenuation protein (TRAP) with anti-TRAP. J Mol Biol (2004) 1.05

The role of human Dicer-dsRBD in processing small regulatory RNAs. PLoS One (2012) 0.97

Domain stabilities in protein kinase R (PKR): evidence for weak interdomain interactions. Biochemistry (2008) 0.97

Are fluorescence-detected sedimentation velocity data reliable? Anal Biochem (2013) 0.92

Energetics of SecA dimerization. J Mol Biol (2011) 0.92

Analysis of high-affinity binding of protein kinase R to double-stranded RNA. Biochemistry (2012) 0.90

Magnesium-dependent interaction of PKR with adenovirus VAI. J Mol Biol (2010) 0.89

Conformational dynamics of the Rpt6 ATPase in proteasome assembly and Rpn14 binding. Structure (2013) 0.87

Heparin activates PKR by inducing dimerization. J Mol Biol (2011) 0.87

Analysis of PKR-RNA interactions by sedimentation velocity. Methods Enzymol (2011) 0.83

Defining the Escherichia coli SecA dimer interface residues through in vivo site-specific photo-cross-linking. J Bacteriol (2013) 0.82

A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma. Cancer (2002) 0.82

Role of the PAS sensor domains in the Bacillus subtilis sporulation kinase KinA. J Bacteriol (2013) 0.81

Analysis of monomeric and dimeric phosphorylated forms of protein kinase R. Biochemistry (2010) 0.80

Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett (2011) 0.78

Analysis of SecA dimerization in solution. Biochemistry (2014) 0.78

Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2). Am J Clin Oncol (2002) 0.75